ZA841766B - Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation - Google Patents
Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparationInfo
- Publication number
- ZA841766B ZA841766B ZA841766A ZA841766A ZA841766B ZA 841766 B ZA841766 B ZA 841766B ZA 841766 A ZA841766 A ZA 841766A ZA 841766 A ZA841766 A ZA 841766A ZA 841766 B ZA841766 B ZA 841766B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapy
- pulmonary
- oedemas
- ischaemias
- ulcerations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833308881 DE3308881A1 (en) | 1983-03-12 | 1983-03-12 | Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and cardiac dysrhythmias and of rheumatic, allergic and asthmatic disorders, oedemas, pulmonary embolisms, pulmonary hypertension, oxygen intoxication and ulceration, pharmaceutical compositions for this purpose and process for the production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA841766B true ZA841766B (en) | 1984-10-31 |
Family
ID=6193304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA841766A ZA841766B (en) | 1983-03-12 | 1984-03-09 | Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS59175469A (en) |
KR (1) | KR840008326A (en) |
DE (1) | DE3308881A1 (en) |
ZA (1) | ZA841766B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE35801E (en) * | 1985-05-20 | 1998-05-19 | Mitsubishi Chemical Corporation | Prophylactic and therapeutic composition for circulatory disorders and method of treatment |
US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
EP2230912A4 (en) * | 2007-11-21 | 2013-05-01 | Teikoku Pharma Usa Inc | Pyrazolone derivative emulsion formulations |
-
1983
- 1983-03-12 DE DE19833308881 patent/DE3308881A1/en not_active Withdrawn
-
1984
- 1984-03-09 ZA ZA841766A patent/ZA841766B/en unknown
- 1984-03-10 JP JP59046368A patent/JPS59175469A/en active Pending
- 1984-03-12 KR KR1019840001264A patent/KR840008326A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS59175469A (en) | 1984-10-04 |
DE3308881A1 (en) | 1984-09-13 |
KR840008326A (en) | 1984-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gueron et al. | Severe myocardial damage and heart failure in scorpion sting: Report of five cases | |
AU2878689A (en) | Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease | |
EP0200406A3 (en) | Novel amino acid derivatives | |
CA2141572A1 (en) | Terfenadine Metabolites and Their Optically Pure Isomers for Treating Allergic Disorders | |
CA2137237A1 (en) | Purified forms of dnase | |
EP0149242A3 (en) | 1-(2-hydroxyaryl)-alcan-1-one oxime, preparation and pharmaceutical use | |
CA2143610A1 (en) | Use of norastemizole for the treatment of allergic disorders | |
DE3062981D1 (en) | Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives | |
EP0190891A3 (en) | Novel amino acid derivatives | |
PT78239B (en) | Process for preparing medicaments based on pyrazolone derivatives and process for using them as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhytm inflammations of the skin and eye and of rheumatic allergic and asthmatic diseases oedemas pulmonary embolisms pulmonary hypertension shock lung oxygen intoxication and ulcerations | |
ZA841766B (en) | Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation | |
Isaac | The “gauntlet” of pellagra | |
US4847283A (en) | Ointment and method for treating skin lesions due to herpes virus | |
Kehl | Dupuytren's contracture as a sequel to coronary artery disease and myocardial infarction | |
ZA84637B (en) | Use of nafazatrom for the therapy of ischaemias,disorders in cardiac rhythm;inflammations of eye and skin;rheumatic,allergic and asthmatic diseases,ards;pulmonary embolisms;oedemes;pulmonary hypertension;oxygen intoxication;and ulcerations | |
SE7900071L (en) | NEW AMINO DERIVATIVES OF PYRAZOLE (1,5-A) S-TRIAZIN, PROCEDURE FOR THEIR PREPARATION AND THEIR THERAPEUTIC USES | |
ES8500055A1 (en) | Application of "Nafazatrom". | |
AU516531B2 (en) | Method and composition forthe therapy of cerebral circulatory diseases | |
JPS5585526A (en) | Remedy for allergic disease | |
von Dohlen et al. | Presyncope and syncope: how to find the cause and avoid staggering costs | |
Gole et al. | Familial exudative vitreoretinopathy. | |
JPS6039011Y2 (en) | skin cold stimulation device | |
Miller | The effect of the pneumatic antishock garment (PASG) on hemodynamics, hemorrhage, and survival in penetrating thoracic aortic injury: Ali J, Vanderby B, Purcell CJ Trauma 31: 846–851 Jun 1991 | |
IT8448370A0 (en) | TRISODE CITRATE USABLE IN THE TREATMENT OF ARTHRITICAL RHEUMATIC DISEASES | |
Ohgushi et al. | Clinical Experience of Disodium Cromoglycate Eye Drops in the Treatment of Allergic Eye Diseases. |